These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A quantitative study of the muscle satellite cells in various neuromuscular disorders. Ishimoto S; Goto I; Ohta M; Kuroiwa Y J Neurol Sci; 1983 Dec; 62(1-3):303-14. PubMed ID: 6668477 [TBL] [Abstract][Full Text] [Related]
5. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders. Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868 [No Abstract] [Full Text] [Related]
6. [Various features of muscle tissue metabolism in various muscular and neuromuscular diseases of a hereditary nature (clinico-histochemical study)]. Anosov NN; Saĭkova LA Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):22-5. PubMed ID: 6952668 [TBL] [Abstract][Full Text] [Related]
7. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases. Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K J Neurol Sci; 1984 Mar; 63(3):345-52. PubMed ID: 6726277 [TBL] [Abstract][Full Text] [Related]
9. MONITORING OF RENAL, HEPATIC AND IMMUNE FUNCTION INDICES IN PATIENTS WITH NEUROMUSCULAR DISORDERS: AMYOTROPHIC LATERAL SCLEROSIS AND DUCHENNE MUSCULAR DYSTROPHY. Kononets O; Karaiev T; Lichman L; Kucher O; Kononets O Georgian Med News; 2022 Jan; (322):131-139. PubMed ID: 35134775 [TBL] [Abstract][Full Text] [Related]
10. The significance of the detection of alkaline phosphatase in the diagnosis of neuromuscular diseases. Schmidt A Biomed Biochim Acta; 1986; 45(1-2):S115-7. PubMed ID: 3964233 [TBL] [Abstract][Full Text] [Related]
11. Electromyographic findings in the so-called non-progressive myopathies. Hausmanowa-Petrusewicz I; Ryniewicz B J Neurol; 1976 Feb; 211(3):241-51. PubMed ID: 55490 [TBL] [Abstract][Full Text] [Related]
12. Muscle biopsy correlated with electromyography. Study of 100 cases. Werneck LC; Lima JG Arq Neuropsiquiatr; 1988 Jun; 46(2):156-65. PubMed ID: 3202713 [TBL] [Abstract][Full Text] [Related]
13. [Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]. Konagaya M; Konagaya Y; Horikawa H; Iida M Rinsho Shinkeigaku; 1990 Oct; 30(10):1078-83. PubMed ID: 1703936 [TBL] [Abstract][Full Text] [Related]
14. [A motor function measurement scale for neuromuscular diseases - description and validation study]. Bérard C; Payan C; Fermanian J; Girardot F; Rev Neurol (Paris); 2006 Apr; 162(4):485-93. PubMed ID: 16585909 [TBL] [Abstract][Full Text] [Related]
16. Swallowing problems in neuromuscular disorders. Willig TN; Paulus J; Lacau Saint Guily J; Béon C; Navarro J Arch Phys Med Rehabil; 1994 Nov; 75(11):1175-81. PubMed ID: 7979925 [TBL] [Abstract][Full Text] [Related]
17. Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease. Shima K Hokkaido Igaku Zasshi; 1984 Mar; 59(2):98-116. PubMed ID: 6430772 [TBL] [Abstract][Full Text] [Related]
18. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders. Zweig MH; Adornato B; Van Steirteghem AC; Engel WK Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757 [TBL] [Abstract][Full Text] [Related]
19. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)]. Kowalewski S; Rotthauwe HW Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500 [No Abstract] [Full Text] [Related]
20. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type]. Pernice W; Beckmann R; Renner S; Wais U Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]